Type III secretion system effector proteins (E. coli O157:H7) (T3SS effectors)

Escherichia coli O157 type III secreted proteins represent a large family of bacterial virulence factors (over 60 identified proteins) deployed by enterohemorrhagic E. coli (EHEC) O157:H7 through a type III secretion system (T3SS) to subvert human cell biology[1][3]. These effector proteins are injected into host intestinal epithelial cells, where they manipulate eukaryotic cellular processes to promote bacterial adhesion, colonization, and the formation of characteristic attaching and effacing lesions[6]. The effector repertoire is remarkably diverse, with genes encoded across multiple chromosomal locations, including within lambdoid prophages that appear to function as evolutionary crucibles for pathogenicity[1]. Rather than a single therapeutic target, this represents a complex virulence mechanism; potential therapeutic approaches would focus on blocking the T3SS apparatus itself or neutralizing specific effectors, though such strategies remain largely investigational and are not currently used clinically.

Other names

T3SS effectorsEsp proteins (E. coli secreted proteins)Nle proteins (non-LEE encoded proteins)LEE-encoded effectors (encoded by the locus of enterocyte effacement)

N/A — These are bacterial proteins involved in host cell invasion and manipulation, not drug targets with established mechanisms of pharmaceutical action.